McKesson shares surged yesterday primarily driven by the announcement that the company has signed an agreement in principle to extend its pharmaceutical distribution partnership with CVS Health through June 2032.
This long-term contract extension provides significant visibility for the company's distribution business, reinforcing investor confidence alongside the company's decision to reaffirm its guidance for the current fiscal year. The positive sentiment surrounding this deal helped the stock decouple from a broader market e